62
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia

, , , , &
Pages 285-290 | Published online: 15 Dec 2015

References

  • GualandroSFFonsecaGHYokomizoIKGualandroDMSuganumaLMCohort study of adult patients with haemoglobin SC disease: clinical characteristics and predictors of mortalityBr J Haematol Epub2015810
  • SerjeantGRAshcroftMTSerjeantBEThe clinical features of haemoglobin SC disease in JamaicaBr J Haematol19732444915014715144
  • PlattOSBrambillaDJRosseWFMortality in sickle cell disease. Life expectancy and risk factors for early deathN Engl J Med199433023163916447993409
  • BallasSKLewisCNNooneAMKrasnowSHKamarulzamanEBurkaERClinical, hematological, and biochemical features of Hb SC diseaseAm J Hematol198213137517137165
  • LebensburgerJDHilliardLMPairLEOsterRHowardTHCutterGRSystematic review of interventional sickle cell trials registered in ClinicalTrials.govClin Trials Epub2015617
  • YawnBPBuchananGRAfenyi-AnnanANManagement of sickle cell disease: summary of the 2014 evidence-based report by expert panel membersJAMA2014312101033104825203083
  • WangWBrugnaraCSnyderCThe effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trialBr J Haematol2011152677177621275961
  • SteinbergMHNagelRLBrugnaraCCellular effects of hydroxyurea in Hb SC diseaseBr J Haematol19979848388449326175
  • RogersZRHydroxyurea therapy for diverse pediatric populations with sickle cell diseaseSemin Hematol1997343 Suppl 342479317200
  • MillerMKZimmermanSASchultzWHWareREHydroxyurea therapy for pediatric patients with hemoglobin SC diseaseJ Pediatr Hematol Oncol200123530630811464988
  • IyerRBaligaRNagelRLMaximum urine concentrating ability in children with Hb SC disease: effects of hydroxyureaAm J Hematol2000641475210815787
  • LoukopoulosDVoskaridouEKalotychouVSchinaMLoutradiATheodoropoulosIReduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in GreeceBlood Cells Mol Dis200026545346611112383
  • YatesAMDedekenLSmeltzerMPLebensburgerJDWangWCRobitailleNHydroxyurea treatment of children with hemoglobin SC diseasePediatr Blood Cancer201360232332522949140
  • WareREHow I use hydroxyurea to treat young patients with sickle cell anemiaBlood2010115265300531120223921
  • WangWCWareREMillerSTHydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)Lancet201137797781663167221571150
  • CharacheSMechanism of action of hydroxyurea in the management of sickle cell anemia in adultsSemin Hematol1997343 Suppl 315219317197
  • SubbannanKUstunCNatarajanKAcute splenic complications and implications of splenectomy in hemoglobin SC diseaseEur J Haematol200983325826019459924
  • SillsRHSplenic function in children with hemoglobin SC disease and sickle beta-thalassemiaJ Natl Med Assoc198375109919946644841
  • AquinoVMNorvellJMBuchananGRAcute splenic complications in children with sickle cell-hemoglobin C diseaseJ Pediatr199713069619659202620
  • HuangYAnanthakrishnanTEidJEHydroxyurea-induced splenic regrowth in an adult patient with severe hemoglobin SC diseaseAm J Hematol200374212512614508799
  • KoduriPRKovarikPAcute splenic sequestration crisis in an adult with sickle beta-thalassemiaAnn Hematol200685963363516705454
  • ClasterSVichinskyEFirst report of reversal of organ dysfunction in sickle cell anemia by the use of hydroxyurea: splenic regenerationBlood1996886195119538822912
  • BarriosNJKirkpatrickDVLohmanDMcMullenCCWilsonWHumbertJRSpleen function in children with sickle B+ thalassemiaJ Natl Med Assoc19918398198221942116
  • CondonPISerjeantGROcular findings in hemoglobin SC disease in JamaicaAm J Ophthalmol19727459219314644739
  • LebensburgerJDSidonioRFDebaunMRSaffordMMHowardTHScarinciICExploring barriers and facilitators to clinical trial enrollment in the context of sickle cell anemia and hydroxyureaPediatr Blood Cancer20136081333133723418000